Nutraceuticals, functional foods and medical foods: Commentary and caveats

Journal of Nutraceuticals, Functional and Medical Foods

Volumn 1, Issue 3, 1998, Pages 73-99

  Murthy, Mahadev ^a,b,c,d,e,f  

^a Nutraceutical Innov Netwk Canada ^*  (United States)

^b UNIVERSITY OF MYSORE   (India)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f Can Nutraceuticais Innov Center   (Canada)

Author keywords

Functional foods; Health care; Medical foods; Nutraceuticals; Science

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASPARTAME; BETA CAROTENE; BIOFLAVONOID; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GROWTH HORMONE; MELATONIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLANT EXTRACT; PRASTERONE; SUCROSE POLYESTER; VITAMIN;

ANTIOXIDANT ACTIVITY; CANCER PREVENTION; CHRONIC DISEASE; DIET SUPPLEMENTATION; ENTERIC FEEDING; FOOD; GINSENG; HEALTH CARE COST; HEALTH CARE DELIVERY; HERBAL MEDICINE; HUMAN; NUTRITION; NUTRITIONAL VALUE; PREVENTIVE MEDICINE; REVIEW; WEIGHT REDUCTION;

ALLIUM SATIVUM; GINKGO BILOBA; PANAX GINSENG;

EID: 0031429319     PISSN: 10894179     EISSN: None     Source Type: Journal    
DOI: 10.1300/j133v01n03_06     Document Type: Review

References (28)

1. Federal Register, 1996: 61: 60661-60671.
2. Talbot, JM. Guidelines for the Scientific Review of Enteral Food Products for Special Medical Purposes, prepared for the Food and Drug Administration under FDA Contract No. 223-88-2124 by the Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD, 1990.
3. Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, Commission on Life Sciences, National Research Council, Recommended Dietary Allowances. 10th ed., National Academy Press, Washington, DC, 1989.
4. Hattan, DG, Mackey DR. A Review of Medical Foods: Enterally Administered Formulations Used in the Treatment of Diseases and Disorders, Food Drug Cosmetic Law Journal 1989:44:479-502.
5. Fisher KD, Talbot JM, Carr CJ. A Review of Foods for Medical Purposes: Specially Formulated Products for Nutritional Management of Medical Conditions, prepared for the Food and Drug Administration under Contract No. FDA 223-75-2090 by the Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD, 1977.
6. H. Rept. 101-538, 101st Cong., 2d sess., 19, Nutrition Labeling and Education Act of 1990, June 13, 1990.
7. FDA Enforcement Report, May 19, 1993, Rockville, MD.
8. FDA Enforcement Report, July 28, 1993, Rockville, MD.
9. Miller HI. Foods of the Future: The New Biotechnology and FDA Regulation. (JAMA) 1993: 269:910-912.
10. Field Testing Genetically Modified Organisms: Frame Work for Discussions, National Academy Press, Washington, DC, 1989.
11. Statement of Policy: foods derived from new plant varieties: Federal Register 57: 22984-23005(1992), May 29, 1992.
12. Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators, JAMA 1995: 273: 607-609.
13. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. New Engl J Med 1993:328: 246-52.
14. Merriam-Webster's Collegiate® Dictionary, Tenth Edition, Merriam-Webster, Incorporated, Springfield, MA, 1995.
15. Gordon D, Rosenthal G, Hart J, Sirot R, Baker AL. Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications. JAMA 1995: 273: 489-490.
16. Clark F. Chaparral-induced toxic hepatitis: California and Texas. Morbidity & Mortality Weekly Report 1992: 41: 812-814.
17. Koff SR. Herbal hepatotoxicity: Revisiting a dangerous alternative. JAMA 1995: 273: 502.
18. Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, norhydroguairetic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukotr. Med. 1984: 13: 53-60.
19. 4 synthesis by 5,8,11,14-eicosa-tetraynoic acid in guinea pig polymorphonuclear leukocytes. J Biol Chem 1981: 256: 4156.
20. Agarwal R, Wang ZY, Bik DP, et al. Norhydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P450-mediated monooxygenase activity in rat epidermal and hepatic microsome. Drug Metab Dispos Biol Fate Chem 1991: 19: 620-624.
21. 450-dependent arachidonic acid metabolism. Arch Biochem Biophys 1988: 261: 257-263.
22. 4. Am J Physiol 1995: 268 (Cell Physiol. 37):C138-C146.
23. 2 in human platelets. Prostaglandins Leukotrienes Essential Fatty Acids 1995: 53: 31-39.
24. Murray M, Haydey RP, Murray RP, Murthy M. Clinical and biochemical effects of flax oil in patients with psoriasis. Abstract, Canadian Dermatology Association, 1996.
25. Murray MT. Understanding the benefits of standardized botanical extracts. Amer J Natural Med 1996: 3: 6-12.
26. Reiser SJ. The Era of the Patient: Using the Experience of Illness in Shaping the Missions of Health Care. JAMA 1993: 269: 1012-1017.
27. Miller RH. Estimating Health Expenditure Growth Under Managed Competition: Science, Simulations, and Scenarios. JAMA 1995: 273: 656-662.
28. Blumenthal D, Epstein AM. The Role of Physicians in the Future of Quality Management. New Engl J Med 1996: 335: 1328-1331.